Technical Analysis for ACHV - Achieve Life Sciences, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Down | Flat |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Pocket Pivot | Bullish Swing Setup | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
200 DMA Support | Bullish | 1.70% | |
Stochastic Buy Signal | Bullish | 1.70% | |
Pocket Pivot | Bullish Swing Setup | 1.70% | |
Volume Surge | Other | 1.70% | |
Oversold Stochastic | Weakness | 1.70% | |
50 DMA Resistance | Bearish | 3.02% | |
Oversold Stochastic | Weakness | 3.02% | |
Bullish Engulfing | Bullish | 0.42% |
Alert | Time |
---|---|
Rose Above Previous Day's High | about 6 hours ago |
10 DMA Resistance | about 6 hours ago |
1.5x Volume Pace | about 6 hours ago |
Up 3% | about 6 hours ago |
Down 1% | about 6 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 08/12/2024
Achieve Life Sciences, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. It is developing Apatorsen to block the production of heat shock protein 27, a cell-survival protein expressed in various types of cancers, including bladder, prostate, breast, pancreatic, and non-small cell lung cancer. The company is headquartered in Bothell, Washington.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Breast Cancer Prostate Cancer Non Small Cell Lung Cancer Treatment Of Breast Cancer Small Cell Lung Cancer Oncolytics Biotech Apatorsen
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Breast Cancer Prostate Cancer Non Small Cell Lung Cancer Treatment Of Breast Cancer Small Cell Lung Cancer Oncolytics Biotech Apatorsen
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 5.98 |
52 Week Low | 3.03 |
Average Volume | 256,198 |
200-Day Moving Average | 4.53 |
50-Day Moving Average | 4.92 |
20-Day Moving Average | 5.01 |
10-Day Moving Average | 4.77 |
Average True Range | 0.26 |
RSI (14) | 45.05 |
ADX | 16.26 |
+DI | 17.59 |
-DI | 19.26 |
Chandelier Exit (Long, 3 ATRs) | 4.80 |
Chandelier Exit (Short, 3 ATRs) | 5.31 |
Upper Bollinger Bands | 5.57 |
Lower Bollinger Band | 4.45 |
Percent B (%b) | 0.29 |
BandWidth | 22.25 |
MACD Line | -0.09 |
MACD Signal Line | -0.05 |
MACD Histogram | -0.0473 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 5.23 | ||||
Resistance 3 (R3) | 5.22 | 5.07 | 5.16 | ||
Resistance 2 (R2) | 5.07 | 4.95 | 5.07 | 5.13 | |
Resistance 1 (R1) | 4.92 | 4.88 | 5.00 | 4.93 | 5.10 |
Pivot Point | 4.77 | 4.77 | 4.80 | 4.77 | 4.77 |
Support 1 (S1) | 4.62 | 4.65 | 4.70 | 4.63 | 4.46 |
Support 2 (S2) | 4.47 | 4.58 | 4.47 | 4.43 | |
Support 3 (S3) | 4.32 | 4.47 | 4.41 | ||
Support 4 (S4) | 4.33 |